Anti-Fibrillin-1 Antibody, clone 6C19 ZooMAb^® Rabbit Monoclonal

rabbit

200

expressed in HEK 293 cells

unconjugated

purified antibody

recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt 312.3 kDa
observed mol wt ~ 35 kDa

human

monkey

antibody small pack of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

IgG

Aligned

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Learn more about ZooMAb here.

Clone 6C19 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Fibrillin-1. It targets an epitope within the N-terminal half.

GST/His-tagged recombinant fragment corresponding to 95 amino acids from the N-terminal half of human Fibrillin-1.

Quality Control Testing
Western Blotting Analysis: A 1:1000 dilution of this antibody detected GST/His-tagged recombinant human Fibrillin-1.Tested applicationsImmunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Fibrillin-1 in human placenta tissue sections.Affinity Binding Assay: A representative lot of this antibody bound Fibrillin 1 recombinant fragment with a KD of 1.7 x 10-6 in an affinity binding assay.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-Fibrillin-1, clone 6C19 ZooMAb, Cat. No. ZRB1019, is a recombinant Rabbit monoclonal antibody that specifically targets Fibrillin-1 and has been tested for use in Affinity Binding Assay, Immunohistochemistry (Paraffin), and Western Blotting.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

30 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Fibrillin-1 (UniProt: P35555; also known as FBN1) is encoded by the FBN1 (also known as FBN) gene (Gene ID: 2200) in human. Fibrillin-1 is a structural component of the 10-12 nm diameter microfibrils of the extracellular matrix that conveys both structural and regulatory properties to load-bearing connective tissues. Fibrillin-1-containing microfibrils provide long-term force bearing structural support. Fibrillin-1 is synthesized with a signal peptide (aa 1-24) and a propeptide (aa 25-44) that are cleaved off to generate the mature Fibrillin-1, which can be further cleaved by furin between residues 2731 and 2732 to produce asprosin (aa 2732-2871). Asprosin serves as a hormone that targets the liver to increase plasma glucose levels. It promotes glucose release from hepatocytes by activating protein kinase A. Fibrillin-1 is reported to play a role in tissue homeostasis through specific interactions with growth factors, such as the bone morphogenetic proteins (BMP), growth and differentiation factors, and latent TGF-beta binding proteins. It is also reported to regulate osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels. It is also shown to negatively regulate osteoclastogenesis by binding and sequestering an osteoclast differentiation and activation factor TNFSF11. Mutations in FBN1 gene are known to cause Marfan syndrome, a disorder of the connective tissue that affects skeletal, ocular, and cardiovascular systems. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1